Breath condensate nitrite correlates with hyperinflation in chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 101, Issue 11, 2007, Pages 2271-2278

  Gessner, Christian ^a   Hammerschmidt, Stefan ^a   Kuhn, Hartmut ^a   Hoheisel, Gerhard ^a   Gillissen, Adrian ^b   Sack, Ulrich ^a   Wirtz, Hubert ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Klinikum St Georg   (Germany)

Author keywords

Breathe tests; Chronic obstructive; Cytokines; Flow cytometry; Nitrites; Pulmonary disease

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMETRY; FEMALE; HUMAN; HYPERINFLATION; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESIDUAL VOLUME; SMOKING; TOTAL LUNG CAPACITY; VOLUNTEER;

AGED; BIOLOGICAL MARKERS; BREATH TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CYTOKINES; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRITES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION;

EID: 34748861504     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.06.024     Document Type: Article

References (35)

1. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
2. Smith A.D., Cowan J.O., Brassett K.P., Herbison G.P., and Taylor D.R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352 (2005) 2163-2173
3. Kharitonov S.A. Exhaled markers of inflammatory lung diseases: ready for routine monitoring?. Swiss Med Wkly 134 (2004) 175-192
4. Carpagnano G.E., Barnes P.J., Francis J., Wilson N., Bush A., and Kharitonov S.A. Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation?. Chest 125 (2004) 2005-2010
5. Gessner C., Scheibe R., Wotzel M., et al. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Med 99 (2005) 1229-1240
6. Gessner C., Hammerschmidt S., Kuhn H., et al. Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury. Chest 124 (2003) 1046-1052
7. Hammerschmidt S., Schiller J., Kuhn H., et al. Influence of tidal volume on pulmonary NO release, tissue lipid peroxidation and surfactant phospholipids. Biochim Biophys Acta 1639 (2003) 17-26
8. Hammerschmidt S., Kuhn H., Sack U., et al. Mechanical stretch alters alveolar type II cell mediator release toward a proinflammatory pattern. Am J Respir Cell Mol Biol 33 (2005) 203-210
9. Gessner C., Kuhn H., Seyfarth H.J., et al. Factors influencing breath condensate volume. Pneumologie 55 (2001) 414-419
10. 15N]nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
11. - in aqueous and protein-containing samples. Nitric Oxide 3 (1999) 225-234
12. Cunningham S., McColm J.R., Ho L.P., Greening A.P., and Marshall T.G. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Respir J 15 (2000) 955-957
13. Sack U., Scheibe R., Wotzel M., et al. Multiplex analysis of cytokines in exhaled breath condensate. Cytometry A 69 (2006) 169-172
14. Huszar E., Vass G., Vizi E., et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 20 (2002) 1393-1398
15. Effros R.M., Hoagland K.W., Bosbous M., et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med 165 (2002) 663-669
16. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-36.
17. Ruppel G.L. Spirometry. Respir Care Clin N Am 3 (1997) 155-181
18. Bucchioni E., Kharitonov S.A., Allegra L., and Barnes P.J. High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir Med 97 (2003) 1299-1302
19. O'Donnell R.A., Peebles C., Ward J.A., et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax 59 (2004) 837-842
20. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
21. Artigas A., Bernard G.R., Carlet J., et al. The American-European consensus conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med 24 (1998) 378-398
22. Demedts I.K., Demoor T., Bracke K.R., Joos G.F., and Brusselle G.G. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 7 (2006) 53
23. Calabrese F., Giacometti C., Beghe B., et al. Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. Respir Res 6 (2005) 14
24. Ho L.P., Innes J.A., and Greening A.P. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 53 (1998) 680-684
25. Edwards Y.S., Sutherland L.M., and Murray A.W. NO protects alveolar type II cells from stretch-induced apoptosis. A novel role for macrophages in the lung. Am J Physiol Lung Cell Mol Physiol 279 (2000) L1236-L1242
26. Hammerschmidt S., Kuhn H., Grasenack T., Gessner C., and Wirtz H. Apoptosis and necrosis induced by cyclic mechanical stretching in alveolar type II cells. Am J Respir Cell Mol Biol 30 (2004) 396-402
27. Rossaint R., Falke K.J., Lopez F., Slama K., Pison U., and Zapol W.M. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328 (1993) 399-405
28. Beloucif S., and Payen D. A European survey of the use of inhaled nitric oxide in the ICU. Working Group on Inhaled NO in the ICU of the European Society of Intensive Care Medicine. Intensive Care Med 24 (1998) 864-877
29. Walmrath D., Schneider T., Schermuly R., Olschewski H., Grimminger F., and Seeger W. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 153 (1996) 991-996
30. Hunt J., Byrns R.E., Ignarro L.J., and Gaston B. Condensed expirate nitrite as a home marker for acute asthma. Lancet 346 (1995) 1235-1236
31. Hunt J.F., Fang K., Malik R., et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 161 (2000) 694-699
32. Jang A.S., Choi I.S., Lee S., et al. Nitric oxide metabolites in induced sputum: a marker of airway inflammation in asthmatic subjects. Clin Exp Allergy 29 (1999) 1136-1142
33. Marteus H., Tornberg D.C., Weitzberg E., Schedin U., and Alving K. Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation. Thorax 60 (2005) 219-225
34. Horvath I., Hunt J., Barnes P.J., et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26 (2005) 523-548
35. O'Donnell D.E., Fluge T., Gerken F., et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 23 (2004) 832-840